Insider Transactions in Q4 2020 at Halozyme Therapeutics, Inc. (HALO)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 21
2020
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
SELL
Open market or private sale
|
Direct |
12,000
-4.47%
|
$504,000
$42.9 P/Share
|
|
Dec 07
2020
|
Kenneth J Kelley Director |
SELL
Open market or private sale
|
Direct |
35,086
-14.94%
|
$1,438,526
$41.0 P/Share
|
|
Dec 02
2020
|
Kenneth J Kelley Director |
SELL
Open market or private sale
|
Direct |
31,792
-11.92%
|
$1,303,472
$41.0 P/Share
|
|
Nov 30
2020
|
Helen Torley PRESIDENT AND CEO |
SELL
Bona fide gift
|
Direct |
10,000
-2.08%
|
-
|
|
Nov 27
2020
|
Kenneth J Kelley Director |
SELL
Open market or private sale
|
Direct |
10,000
-3.61%
|
$410,000
$41.25 P/Share
|
|
Nov 25
2020
|
Kenneth J Kelley Director |
SELL
Open market or private sale
|
Direct |
9,671
-3.38%
|
$396,511
$41.5 P/Share
|
|
Nov 25
2020
|
Helen Torley PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
50,000
-4.83%
|
$2,000,000
$40.67 P/Share
|
|
Nov 25
2020
|
Helen Torley PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+8.61%
|
$700,000
$14.66 P/Share
|
|
Nov 25
2020
|
James M Daly |
SELL
Open market or private sale
|
Direct |
10,363
-33.04%
|
$414,520
$40.41 P/Share
|
|
Nov 25
2020
|
Jeffrey William Henderson |
SELL
Open market or private sale
|
Direct |
24,498
-33.97%
|
$979,920
$40.08 P/Share
|
|
Nov 20
2020
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
SELL
Open market or private sale
|
Direct |
12,000
-4.16%
|
$456,000
$38.64 P/Share
|
|
Oct 20
2020
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
SELL
Open market or private sale
|
Direct |
12,000
-7.56%
|
$360,000
$30.43 P/Share
|